Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-06-30Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label TrialClinicalTrials.gov · 2026-06-25Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-22Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-21Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-05-31EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-05-31EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSIONValue in Health · 2026-05-31Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-05-28Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual AnhedoniaClinicalTrials.gov · 2026-05-26Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-05-17Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-06Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education Health and Sport · 2026-05-06A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in DepressionClinicalTrials.gov · 2026-03-29Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand MechanismClinicalTrials.gov · 2026-03-19Psilocybin effects on brain functional connectivity: a systematic review of fMRI studiesDiscover Mental Health · 2026-03-18Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-18Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical TrialClinicalTrials.gov · 2026-03-17Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.ClinicalTrials.gov · 2026-03-04Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant DepressionValue in Health Regional Issues · 2026-02-28Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive ImpairmentClinicalTrials.gov · 2026-02-24Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical TrialClinicalTrials.gov · 2026-02-11PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-01-26A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone TreatmentClinicalTrials.gov · 2026-01-22The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationClinicalTrials.gov · 2025-12-23Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who StutterClinicalTrials.gov · 2025-12-21Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2025-12-18A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced CancerClinicalTrials.gov · 2025-12-03Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future DirectionsEmerging Trends in Drugs Addictions and Health · 2025-11-30Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care PatientsJournal of Health Service Psychology · 2025-11-30A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant DepressionClinicalTrials.gov · 2025-11-18Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.ClinicalTrials.gov · 2025-11-18Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-10-31Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility StudyClinicalTrials.gov · 2025-10-09S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityClinicalTrials.gov · 2025-07-17Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical TrialClinicalTrials.gov · 2025-04-24Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-23Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAINClinicalTrials.gov · 2025-03-29PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05A qualitative analysis of the psychedelic mushroom come-up and come-downnpj Mental Health Research · 2025-02-06A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major DepressionClinicalTrials.gov · 2025-01-19Study finds encouraging results in psilocybin treatment for TRD patientsMental Health Weekly · 2025-01-09Moral Considerations and the Experience of Ego Dissolution: Insights from PsilocybinAsian Journal of Ethics in Health and Medicine · 2024-12-31A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy StudyClinicalTrials.gov · 2024-10-29Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2024-10-17Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-13Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerNature Mental Health · 2024-10-06Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcomenpj Mental Health Research · 2024-10-05Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal TrialsJournal of Complementary Medicine & Alternative Healthcare · 2024-09-16An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)ClinicalTrials.gov · 2024-08-08Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-04Psilocybin as a new way for depression treatmentJournal of Education Health and Sport · 2024-05-14Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2024-04-01Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a DecadeJournal of Adolescent Health · 2024-02-25The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effectsnpj Mental Health Research · 2024-02-19Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and ReschedulingHealth Law Outlook · 2023-12-31Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledgeJournal of Education Health and Sport · 2023-12-29The potential use of psilocybin in psychiatryLithuanian University of Health Sciences · 2023-11-13Assessing Metro Vancouver Residents’ Knowledge and Opinions of PsilocybinBCIT Environmental Public Health Journal · 2023-10-11Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?International Journal of Mental Health Nursing · 2023-08-16use of psilocybin in the treatment of psychiatric disorders - reviewJournal of Education Health and Sport · 2023-08-14Psilocybin's Emerging Role in Combating Depressive DisorderJournal of Education Health and Sport · 2023-08-07Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-01Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-19A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-07The psychedelic renaissance: can psilocybin possibly combat depression?International Journal of Surgery Global Health · 2022-10-31The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.ClinicalTrials.gov · 2022-10-24Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a WorkshopNational Academies Press (US), Washington (DC) · 2022-08-31Use of psychedelics in the Czech Republic: results of recent population surveys.Central European Journal of Public Health · 2022-08-31Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.International Journal of Environmental Research and Public Health · 2022-05-28Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant DepressionClinicalTrials.gov · 2022-05-19A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionClinicalTrials.gov · 2022-02-13Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use DisordersCanadian Agency for Drugs and Technologies in Health, Ottawa (ON) · 2021-05-31A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature reviewBrazilian Journal of Health Review · 2021-05-02O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depressionBrazilian Journal of Health Review · 2021-04-18Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer PatientsClinicalTrials.gov · 2020-10-19Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin MushroomsJournal of Healthcare · 2020-08-18Clinical potential of psilocybin as a treatment for mental health conditions.Mental Health Clinician · 2016-12-31Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.Journal of Psychosocial Nursing and Mental Health Services · 2016-06-3014C-Psilocin tissue distribution in pregnant rats after intravenous administrationFunctional Foods in Health and Disease · 2014-07-26Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive DisorderYearbook of Psychiatry and Applied Mental Health · 2007-12-31